These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


145 related items for PubMed ID: 12151438

  • 41. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutation associated with a congenital bilateral absence of vas deferens.
    Sakamoto H, Yajima T, Suzuki K, Ogawa Y.
    Int J Urol; 2008 Mar; 15(3):270-1. PubMed ID: 18304229
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Cystic fibrosis mutation screening in CBAVD patients and men with obstructive azoospermia or severe oligozoospermia.
    Kanavakis E, Tzetis M, Antoniadi T, Pistofidis G, Milligos S, Kattamis C.
    Mol Hum Reprod; 1998 Apr; 4(4):333-7. PubMed ID: 9620832
    [Abstract] [Full Text] [Related]

  • 46. Genetic investigations of CFTR mutations in congenital absence of vas deferens, uterus, and vagina as a cause of infertility.
    Radpour R, Gourabi H, Dizaj AV, Holzgreve W, Zhong XY.
    J Androl; 2008 Apr; 29(5):506-13. PubMed ID: 18567645
    [Abstract] [Full Text] [Related]

  • 47. Association of cystic fibrosis genetic modifiers with congenital bilateral absence of the vas deferens.
    Havasi V, Rowe SM, Kolettis PN, Dayangac D, Sahin A, Grangeia A, Carvalho F, Barros A, Sousa M, Bassas L, Casals T, Sorscher EJ.
    Fertil Steril; 2010 Nov; 94(6):2122-7. PubMed ID: 20100616
    [Abstract] [Full Text] [Related]

  • 48. Analysis of the whole CFTR coding regions and splice junctions in azoospermic men with congenital bilateral aplasia of epididymis or vas deferens.
    Culard JF, Desgeorges M, Costa P, Laussel M, Razakatzara G, Navratil H, Demaille J, Claustres M.
    Hum Genet; 1994 Apr; 93(4):467-70. PubMed ID: 7513294
    [Abstract] [Full Text] [Related]

  • 49. Structural analysis of CFTR gene in congenital bilateral absence of vas deferens.
    Jézéquel P, Dorval I, Fergelot P, Chauvel B, Le Treut A, Le Gall JY, Le Lannou D, Blayau M.
    Clin Chem; 1995 Jun; 41(6 Pt 1):833-5. PubMed ID: 7539342
    [Abstract] [Full Text] [Related]

  • 50. Cystic fibrosis as a cause of infertility.
    Jarzabek K, Zbucka M, Pepiński W, Szamatowicz J, Domitrz J, Janica J, Wołczyński S, Szamatowicz M.
    Reprod Biol; 2004 Jul; 4(2):119-29. PubMed ID: 15297887
    [Abstract] [Full Text] [Related]

  • 51. Nasal epithelial ion transport and genetic analysis of infertile men with congenital bilateral absence of the vas deferens.
    Osborne LR, Lynch M, Middleton PG, Alton EW, Geddes DM, Pryor JP, Hodson ME, Santis GK.
    Hum Mol Genet; 1993 Oct; 2(10):1605-9. PubMed ID: 7505692
    [Abstract] [Full Text] [Related]

  • 52. Management of male infertility due to congenital bilateral absence of vas deferens should not ignore the diagnosis of cystic fibrosis.
    Grzegorczyk V, Rives N, Sibert L, Dominique S, Macé B.
    Andrologia; 2012 Oct; 44(5):358-62. PubMed ID: 22390181
    [Abstract] [Full Text] [Related]

  • 53. Significance of CFTR gene mutations in patients with congenital aplasia of vas deferens with special regard to renal aplasia.
    Schwarzer JU, Schwarz M.
    Andrologia; 2012 Oct; 44(5):305-7. PubMed ID: 22340520
    [Abstract] [Full Text] [Related]

  • 54. CFTR (TG)m(T)n polymorphism in patients with CBAVD in a population expressing low incidence of cystic fibrosis.
    Chiang HS, Lu JF, Liu CH, Wu YN, Wu CC.
    Clin Genet; 2009 Sep; 76(3):282-6. PubMed ID: 19737283
    [Abstract] [Full Text] [Related]

  • 55. Genetic findings in congenital bilateral aplasia of vas deferens patients and identification of six novel mutatations. Mutations in brief no. 138. Online.
    de Meeus A, Guittard C, Desgeorges M, Carles S, Demaille J, Claustres M.
    Hum Mutat; 1998 Sep; 11(6):480. PubMed ID: 10200050
    [Abstract] [Full Text] [Related]

  • 56. Cystic fibrosis transmembrane conductance regulator mutations and polymorphisms associated with congenital bilateral absence of vas deferens in a restricted group of patients from North Africa.
    Boudaya M, Fredj SH, Haj RB, Khrouf M, Bouker A, Halouani L, Messaoud T.
    Ann Hum Biol; 2012 Jan; 39(1):76-9. PubMed ID: 22148899
    [Abstract] [Full Text] [Related]

  • 57. A novel missense mutation D513G in exon 10 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene identified in a French CBAVD patient. Mutations in brief no. 175. Online.
    Bienvenu T, Bousquet S, Vidaud D, Hubert D, Francoual C, Beldjord C, Kaplan JC.
    Hum Mutat; 1998 Jan; 12(3):213-4. PubMed ID: 10651488
    [Abstract] [Full Text] [Related]

  • 58. [An analysis of the mutations in the gene of the mucoviscidosis transmembrane regulator protein (MTRP) in patients with congenital bilateral aplasia of the vas deferens].
    Gusak NM, Gorovenko NG, Gorpinchenko II, Karmeliuk SO.
    Tsitol Genet; 1996 Jan; 30(5):48-53. PubMed ID: 9026991
    [Abstract] [Full Text] [Related]

  • 59. Congenital bilateral absence of vas deferens with a new missense mutation (P499A) in the CFTR gene.
    Arduino C, Ferrone M, Brusco A, Garnerone S, Fontana D, Rolle L, Carbonara AO.
    Clin Genet; 1998 Mar; 53(3):202-4. PubMed ID: 9630075
    [Abstract] [Full Text] [Related]

  • 60. CFTR mutation analysis of a Caucasian father with congenital bilateral absence of vas deferens, a Taiwanese mother, and twins resulting from ICSI procedure.
    Chiang HS, Wu CC, Wu YN, Lu JF, Lin GH, Hwang JL.
    J Formos Med Assoc; 2008 Sep; 107(9):736-40. PubMed ID: 18796364
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.